These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36428284)

  • 21. Long-term Impact of CALGB 9343 on Radiation Utilization.
    Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
    J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
    Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
    Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of radiation therapy for older women with early breast cancer.
    Smith BD; Gross CP; Smith GL; Galusha DH; Bekelman JE; Haffty BG
    J Natl Cancer Inst; 2006 May; 98(10):681-90. PubMed ID: 16705122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
    Chen J; Wu X; Christos PJ; Formenti S; Nagar H
    Breast Cancer Res; 2018 Apr; 20(1):26. PubMed ID: 29661221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
    Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
    Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Out-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans.
    Wu VS; Khlopin M; Chadha M; Smith-Graziani DJ; Jagsi R; McClelland S
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1379-1385. PubMed ID: 38432284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.
    Albert JM; Pan IW; Shih YC; Jiang J; Buchholz TA; Giordano SH; Smith BD
    Cancer; 2012 Oct; 118(19):4642-51. PubMed ID: 22890779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis.
    Yuan C; Xie Z; Bian J; Huo J; Daily K
    Breast Cancer Res Treat; 2020 Apr; 180(3):819-827. PubMed ID: 32172303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial disparities in treatment and survival of male breast cancer.
    Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
    J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
    Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D
    JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer.
    Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Partridge EE; Rocque GB
    Cancer; 2018 Feb; 124(3):475-481. PubMed ID: 29053170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
    Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017.
    Zhang H; Barner JC; Moczygemba LR; Rascati KL; Park C; Kodali D
    Breast Cancer Res Treat; 2022 Jun; 193(3):695-705. PubMed ID: 35449473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
    Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.
    LeMasters TJ; Madhavan SS; Sambamoorthi U; Vyas AM
    J Womens Health (Larchmt); 2017 Jul; 26(7):735-744. PubMed ID: 28170302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.